Medical Devices

AI threatens health data privacy: Report

19-Feb-2019 By Melissa Fassbender

Artificial intelligence advances threaten data privacy, according to a new study, which found it is possible to re-identify individuals using their physical activity data.

SCOPE 2019

Shimmer shines with a new wearable platform for clinical trials

19-Feb-2019 By Melissa Fassbender

Shimmer designed its new Verisense platform from the ground up after finding that current activity trackers fail to meet the “basic needs of the clinical research market,” says company executive.

SCOPE 2019

Tech is advancing, but uncertainty creates an ‘opposing effect’ to positive movement

18-Feb-2019 By Melissa Fassbender

The industry has advanced to a point that should justify the financial investment in new technology, though uncertainty, and a lack of support, are hindering movement.

Medidata, Cognizant form strategic alliance to empower digital transformation

12-Feb-2019 By Melissa Fassbender

Medidata is working with Cognizant to develop a set of services that will provide pharma, biotech, CROs and others with the capabilities to “digitally transform” their research and commercialization.

Will advances in digital health be driven by a combination of Silicon Valley know-how and clinical trial expertise?

12-Feb-2019 By Melissa Fassbender

It will take a marriage between Silicon Valley and clinical trials expertise to drive innovation in the digital health space, which is being held back by uncertainty – and a reluctance that is keeping industry executives up at night.

Report: Digital health market raised $9.5bn in 2018, analytics and mHealth among ‘big winners’

25-Jan-2019 By Melissa Fassbender

Digital health companies raked in more than $9.5bn as part of 698 global venture capital deals last year – with data analytics and mHealth apps leading the pack among the top-funded categories.

Parkinson’s disease clinical trials: Challenges, advancements, and the role of technology

09-Jan-2019 By Melissa Fassbender

For research in areas such as Parkinson’s disease, digital endpoints may soon be used as primary endpoints, allowing for in-home clinical trials to be conducted over longer periods of time, says CRO.

Apptomics aims to establish its digital platform as the standard for monitoring movement disorders

08-Jan-2019 By Melissa Fassbender

Apptomics is working with BBK and Biotaware to develop the remote health-monitoring platform, which recently served as a digital biomarker to evaluate treatment effects as part of an essential tremor clinical trial.

Digital tech exploded in 2018: Will 2019 see broad adoption?

04-Jan-2019 By Melissa Fassbender

Awareness around the potential opportunities created by artificial intelligence has never been higher, but pharma’s biggest challenge in 2019 will be adopting and scaling the right technology to improve patient outcomes, says an industry executive.

2018 regulatory round-up: Patient safety, data transparency, innovative trial designs

18-Dec-2018 By Melissa Fassbender

Global regulatory agencies had a busy 2018. Here, we take a look back at some of the key developments throughout the year, as the industry navigated challenging politics, pressure to increase transparency, and the rapidly evolving digital health space.

Histopathology providers merge to serve biopharma, CRO industry as single company backed by PE

12-Dec-2018 By Melissa Fassbender

Histo-Scientific Research Laboratories and Vet Path Services have merged to create one company dedicated to providing histology, pathology, and archiving services to the biopharmaceutical, medical device, and contract research industries.

FDA’s MyStudies release is a ‘major milestone’ with ‘profound’ implications, says Iqvia

04-Dec-2018 By Melissa Fassbender

The FDA recently released open source code and technical documents for its new mobile app – MyStudies – which is designed to collect information about medication use, health system touchpoints, and patient-reported outcomes.

The top 15 wearables for incorporating real-world data into clinical trials

04-Dec-2018 By Melissa Fassbender

Litmus Health’s profile of the wearables market names the top 15 devices today available to researchers incorporating real-life data into studies and trials – with a focus on data quality and transparency.

AAPS PharmSci 360 preview: ‘Small-conference feel and big-conference breadth’

30-Oct-2018 By Melissa Fassbender

AAPS PharmSci 360 is a new conference this year, created in response to a desire for “fresh science,” specifically with chemical and biomolecular components. So what can you expect?

‘The opportunities for AI to revolutionize the pharmaceutical industry are clear’: Report

11-Oct-2018 By Melissa Fassbender

Researchers are using artificial intelligence to catalyze drug discovery and preclinical drug development - improving predictive models to guide efficient design and optimizing multi-drug regimens, as two recent examples.